One of the main benefits of IV Therapy is fast, more effective results from vitamins and minerals without gastrointestinal side effects, absorption issues, or loss of potency
For patients using Ozempic for glycaemic control, missing a week may result in elevated blood sugar readings, though the effect is typically gradual rather than sudden due to the medication's long duration of action
Considerations and Next Steps Research Limitations: Current evidence is preliminary
Source: Polaris Market Research Analysis Industry Developments February 2025: Biocon launched its GLP-1 peptide liraglutide in the UK under two brand names: Liraglutide Biocon (for diabetes, similar to Victoza) and Biolide (for chronic weight management, similar to Saxenda)
Which Will Be the Biggest Region in the GLP-1 Receptor Agonist Market in 2030 North America will be the largest region in the GLP-1 receptor agonist market in 2030, valued at $88,912 million